Free Trial
NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

Bioceres Crop Solutions logo
$6.46 +0.10 (+1.57%)
(As of 11/20/2024 ET)

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Key Stats

Today's Range
$6.35
$6.57
50-Day Range
$6.08
$8.60
52-Week Range
$5.71
$14.05
Volume
176,754 shs
Average Volume
91,033 shs
Market Capitalization
$406.01 million
P/E Ratio
323.16
Dividend Yield
N/A
Price Target
$12.13
Consensus Rating
Buy

Company Overview

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Bioceres Crop Solutions Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
53rd Percentile Overall Score

BIOX MarketRank™: 

Bioceres Crop Solutions scored higher than 53% of companies evaluated by MarketBeat, and ranked 87th out of 138 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bioceres Crop Solutions has only been the subject of 4 research reports in the past 90 days.

  • Read more about Bioceres Crop Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Bioceres Crop Solutions are expected to grow by 416.67% in the coming year, from $0.12 to $0.62 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bioceres Crop Solutions is 323.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 131.22.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bioceres Crop Solutions is 323.16, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 23.97.

  • Price to Book Value per Share Ratio

    Bioceres Crop Solutions has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Bioceres Crop Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    2.32% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently increased by 20.69%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bioceres Crop Solutions does not currently pay a dividend.

  • Dividend Growth

    Bioceres Crop Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.32% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently increased by 20.69%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Bioceres Crop Solutions has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Bioceres Crop Solutions this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    Only 2 people have added Bioceres Crop Solutions to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

BIOX Stock News Headlines

Tesla Execs are Freaking Out
It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.
Oppenheimer Sticks to Its Buy Rating for Bioceres Crop Solutions (BIOX)
Bioceres Crop Solutions Reports Q1 2025 Financial Results
Bioceres Crop Solutions: Resilience in Fiscal First Quarter
See More Headlines

BIOX Stock Analysis - Frequently Asked Questions

Bioceres Crop Solutions' stock was trading at $13.73 at the start of the year. Since then, BIOX stock has decreased by 52.9% and is now trading at $6.46.
View the best growth stocks for 2024 here
.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) released its quarterly earnings data on Monday, November, 11th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of $0.02 by $0.11. The company earned $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a trailing twelve-month return on equity of 0.68% and a net margin of 0.53%.

Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering on Wednesday, February 7th 2018. The company issued 11,800,000 shares at $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey acted as the underwriters for the IPO and Mirabaud Securities was co-manager.

Top institutional investors of Bioceres Crop Solutions include Fourth Sail Capital LP (5.05%), Royce & Associates LP (0.36%), Wellington Management Group LLP (0.34%) and Stifel Financial Corp (0.06%).

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Builders FirstSource (BLDR) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
11/11/2024
Today
11/20/2024
Next Earnings (Estimated)
2/13/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
Trading
Current Symbol
NASDAQ:BIOX
Fax
N/A
Employees
500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.13
High Stock Price Target
$13.00
Low Stock Price Target
$9.50
Potential Upside/Downside
+87.7%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
6 Analysts

Profitability

Net Income
$3.24 million
Pretax Margin
1.33%

Debt

Sales & Book Value

Annual Sales
$464.80 million
Cash Flow
$0.41 per share
Book Value
$5.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$406.01 million
Optionable
Optionable
Beta
0.49
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:BIOX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners